Treatment of tracheal tumors.
The evidence for the treatment of tracheal tumors rests on a small number of single-institution series, national surveys, and epidemiologic studies. From this evidence, the following observations have been made: tracheal tumors are rare and must be identified among a much larger number of metastatic malignant tracheal lesions; most tracheal tumors are malignant; most tracheal tumors in selected series are resectable; and survival after resection exceeds survival after nonoperative treatment, even if resection margins are close. A discussion of evaluation and treatment of these tumors in this review proceeds along a systematic series of questions.
Gaissert
Henning A
HA
Division of Thoracic Surgery, Massachusetts General Hospital and Department of Surgery, Harvard Medical School, Boston, Massachusetts 02114, USA. hgaissert@partners.org
Honings
Jimmie
J
Gokhale
Manjusha
M
D006801:Humans; D008197:Lymph Node Excision; D020360:Neoadjuvant Therapy; D011183:Postoperative Complications / Q000209:etiology; D012307:Risk Factors; D015607:Stents; D014132:Trachea / Q000601:surgery; D014134:Tracheal Neoplasms / Q000175:diagnosis / Q000628:therapy*